<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03820427</url>
  </required_header>
  <id_info>
    <org_study_id>MBW-asthma</org_study_id>
    <nct_id>NCT03820427</nct_id>
  </id_info>
  <brief_title>Evaluation of Novel Lung Function Parameters in Patients With Bronchial Asthma</brief_title>
  <official_title>Evaluation of Novel Lung Function Parameters in Patients With Bronchial Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsmedizin Mannheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsmedizin Mannheim</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current guideline-based criteria defining bronchial asthma do not always meet the challenges
      set by the complex pathophysiology of the disease. The investigators therefore aimed to
      evaluate novel or not widely used functional diagnostic approaches for the detection and
      therapeutic monitoring of patients with asthma.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Global ventilation heterogeneity</measure>
    <time_frame>30 minutes</time_frame>
    <description>lung clearance index (LCI) derived from sulphur hexafluoride multiple breath washout</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Local ventilation heterogeneity</measure>
    <time_frame>30 minutes</time_frame>
    <description>Sacin, Scond (Phase III slopes) derived from sulphur hexafluoride multiple breath washout</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">147</enrollment>
  <condition>Bronchial Asthma</condition>
  <condition>Pulmonary Healthy Controls</condition>
  <arm_group>
    <arm_group_label>bronchial asthma</arm_group_label>
    <description>Patients with known or suspected asthma.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pulmonary healthy controls</arm_group_label>
    <description>Patients without known or suspected pulmonary disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>impulse oscillometry</intervention_name>
    <description>impulse oscillometry</description>
    <arm_group_label>bronchial asthma</arm_group_label>
    <arm_group_label>pulmonary healthy controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>multiple breath washout test</intervention_name>
    <description>multiple breath washout test</description>
    <arm_group_label>bronchial asthma</arm_group_label>
    <arm_group_label>pulmonary healthy controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>body plethysmography</intervention_name>
    <description>body plethysmography</description>
    <arm_group_label>bronchial asthma</arm_group_label>
    <arm_group_label>pulmonary healthy controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with indication for routine lung function testing
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  known or suspected bronchial asthma

          -  known or suspected obstructive ventilation disorder

          -  pulmonary healthy controls

        Exclusion Criteria:

          -  pregnancy

          -  inability to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 22, 2019</study_first_submitted>
  <study_first_submitted_qc>January 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2019</study_first_posted>
  <last_update_submitted>January 27, 2019</last_update_submitted>
  <last_update_submitted_qc>January 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsmedizin Mannheim</investigator_affiliation>
    <investigator_full_name>Dr. Frederik Trinkmann</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

